Accenture and Bristol-Myers Squibb have formed a pharmacovigilance centre in Chennai, India. It is the first joint centre for adverse event report processing, medical review and reporting. The centre will be operated by some 140 Accenture employees.
The pharmacovigilance centre is part of Accenture’s life science facilities in Bangalore and Chennai that Bristol-Myers Squibb already uses under a multi-year R&D agreement signed in April 2007. Submitted by www.jobs4dd.com, listing the latest internation jobs in the drug development and biopharm sectors.
